Authors:
Ibrahim, NK
Valero, V
Rahman, Z
Theriault, RL
Walters, RS
Buzdar, AU
Booser, DJ
Holmes, FA
Murray, DJ
Willey, J
Bast, R
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase I-II vinorelbine (Navelbine((R))) by continuous infusion in patientswith metastatic breast cancer: Cumulative toxicities limit dose escalation, CANCER INV, 19(5), 2001, pp. 459-466
Authors:
Brito, RA
Valero, V
Buzdar, AU
Booser, DJ
Ames, F
Strom, E
Ross, M
Theriault, RL
Frye, D
Kau, SW
Asmar, L
McNeese, M
Singletary, SE
Hortobagyi, GN
Citation: Ra. Brito et al., Long-term results of combined-modality therapy for locally advanced breastcancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience, J CL ONCOL, 19(3), 2001, pp. 628-633
Authors:
Hortobagyi, GN
Buzdar, AU
Theriault, RL
Valero, V
Frye, D
Booser, DJ
Holmes, FA
Giralt, S
Khouri, I
Andersson, B
Gajewski, JL
Rondon, G
Smith, TL
Singletary, SE
Ames, FC
Sneige, N
Strom, EA
McNeese, MD
Deisseroth, AB
Champlin, RE
Citation: Gn. Hortobagyi et al., Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma, J NAT CANC, 92(3), 2000, pp. 225-233
Authors:
Ibrahim, NK
Valero, V
Theriault, RL
Willey, J
Walters, RS
Buzdar, AU
Booser, DJ
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer, AM J CL ONC, 23(2), 2000, pp. 117-121
Authors:
Booser, DJ
Walters, RS
Holmes, FA
Hortobagyi, GN
Citation: Dj. Booser et al., Continuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatinfor relapsed metastatic breast cancer: A phase II study, AM J CL ONC, 23(1), 2000, pp. 40-41
Authors:
Holmes, FA
Valero, V
Walters, RS
Theriault, RL
Booser, DJ
Gibbs, H
Fraschini, G
Buzdar, AU
Willey, J
Frye, D
Asmar, L
Hortobagyi, GN
Citation: Fa. Holmes et al., Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results, ANN ONCOL, 10(4), 1999, pp. 403-411
Authors:
Buzdar, AU
Singletary, SE
Theriault, RL
Booser, DJ
Valero, V
Ibrahim, N
Smith, TL
Asmar, L
Frye, D
Manuel, N
Kau, SW
McNeese, M
Strom, E
Hunt, K
Ames, F
Hortobagyi, GN
Citation: Au. Buzdar et al., Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer, J CL ONCOL, 17(11), 1999, pp. 3412-3417